Overview of Plasmapheresis Market: Biopharmaceutical Companies to Represent a Leading Revenue Contributor Throughout 2026

Fact.MR Fact.MR

Rockville, US, 2018-Jun-29 — /EPR Network/ — Growing prevalence of stomach diseases, heart diseases, and autoimmune diseases has led to surge in production of biopharmaceutical medications. With the increasing production of biopharmaceutical medications, demand for plasma will continue to remain high. In addition, healthcare professionals are increasingly conducting plasmapheresis in order to perform extracorporeal therapy for the treatment of autoimmune diseases. Leading companies are focusing on offering innovative features in range of plasmapheresis devices to attain a competitive edge in the global plasmapheresis market.

Request Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=351

In order to offer enhanced customer experience, leading manufacturers are incorporating advanced features in the plasmapheresis devices such as apheresis machines. Manufacturers are integrating safety features such as fluid sensors, pressure monitors, and low anti-coagulant ratios in the plasmapheresis devices to offer convenience while conducting treatment procedures. In addition, these devices are equipped with built-in wireless features that allows it to connect with other devices and share important data. Besides treatment of autoimmune diseases, plasmapheresis is also conducted for production of biopharmaceutical medications. Attributed to these factors, leading manufacturers are focusing on developing application-specific devices to expand customer base.

Over US$ 1,500 Mn Opportunity in Global Plasmapheresis Market

According to Fact.MR, the global plasmapheresis market is expected to reach a value of more than US$ 1,500 Mn by 2026-end. As the need for conducting research and develop innovation treatment solutions persists, demand for plasma is likely to remain high in the biopharmaceutical companies. Healthcare professionals are increasingly conducting plasmapheresis for the treatment of various autoimmune diseases. Prevalence of autoimmune diseases such as rheumatoid arthritis, type 1 diabetes, lupus, celiac diseases, and temporal arthritis has led healthcare professionals to perform extracorporeal therapy. Growing need to conduct extracorporeal therapy has further led the healthcare professionals to conduct plasmapheresis.

Leading manufacturers are focusing on integrating innovative technological solutions in order to enhance customer experience. In addition, growing need to donate blood products due to increasing prevalence of heart diseases, cancer, anaemia, blood loss, and child birth has revved up demand to conduct plasmapheresis. In order to upgrade and develop innovative treatment techniques, healthcare institutions are focusing on investing in research and development through the process of fractionation.

View Full Report with TOC@ https://www.factmr.com/report/351/plasmapheresis-market

As the need for conducting plasmapheresis persists, demand for plasmapheresis devices will continue to remain high in the healthcare industry. In terms of revenue, instruments is projected to represent the highest growth in the global market by the end of 2026. On the other hand, disposables will continue to represent the fastest growth in the global market throughout 2026.

Demand for plasmapheresis devices will continue to remain high in biopharmaceutical companies. In terms of revenue, the biopharmaceutical companies is projected to generate significant revenues in the global market by 2017-end. In contrary, sales of the plasmapheresis devices among other end users will continue to record the fastest growth in the global market throughout 2026. With the growing need to collect plasma for production of biopharmaceutical medications, demand for conducting plasmapheresis will continue to increase. In terms of revenue, plasma collection application is projected to record a robust revenue growth in the global market by 2026-end. However, centrifugation application will continue to represent the fastest growth in the global market throughout 2026.

Major players operating in the global market are Kaneka Corporation, Kawasumi Laboratories, Inc., Fresenius SE & Co. KGaA, Baxter Internationalaq Inc, B Braun Melsungen AG, Terumo Corporation, Asahi Kasei Kuraray Medical, and Haemonetics Corporation.

Buy this Report@ https://www.factmr.com/checkout/351/S

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/

Matched content

Editor’s pick

Express Press Release Distribution